IL-4 Level in Rifampicin-Sensitive and Rifampicin-Resistant Lung Tuberculosis Patients

Authors

  • Joko Susanto Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya
  • Jusak Nugraha Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya
  • Soedarsono Soedarsono Department of Pulmonology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

DOI:

https://doi.org/10.24293/ijcpml.v27i1.1606

Keywords:

IL-4, lung tuberculosis, sensitive, resistant, rifampicin

Abstract

Tuberculosis remains a global health burden. Mycobacterium tuberculosis infection causes humoral and cellular responses. Macrophages of patients with pulmonary tuberculosis evolve M1 polarization that blocks infection or immunosuppressive M2, promoting tissue repair mediated by IL-4, IL-10, and IL-13. Previous research showed a decrease of IL-4R and IL-10 expression in lung macrophages of anti-TB drug resistance. A molecular test can detect rifampicin- resistance. There has been no study, which showed the difference in serum IL-4 levels in rifampicin-sensitive and rifampicin-resistant tuberculosis patients. This study aimed to determine the difference between circulating IL-4 levels in rifampicin-sensitive and rifampicin-resistant pulmonary tuberculosis patients. This cross-sectional observational study consecutively recruited subjects based on positive molecular and acid-fast bacilli microscopic examination from MDR-TB Clinic of the Dr. Soetomo Hospital between December 2018 to March 2019. Subjects were classified into a rifampicin-sensitive and rifampicin-resistant group. On ELISA measurement, IL-4 data were analyzed with SPSS version 17. Mann-Whitney U test and ROC analysis tests were performed, and p < 0.05 was significant for α=0.05 (95% CI). There was significant difference between rifampicin-sensitive group (420±281 pg/mL) and rifampicin-resistant group (253±279 pg/mL) (p=0.014). Receiver operating characteristics analysis showed AUC 0.70, the sensitivity of 81.5%, the specificity of 63.6%, and the cut-off value of 235.6 pg/mL. There was a significantly higher level of circulating IL-4 in the rifampicin-sensitive group than the rifampicin-resistant group. IL-4 level in healthy subjects should be measured as the normal value in the population. Immunology and metabolic parameters should be performed to increase sample homogeneity. Further study was also needed to understand the IL-4 role in rifampicin resistance of lung tuberculosis patients in the Indonesia population.

Downloads

Download data is not yet available.

Author Biographies

Joko Susanto, Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Jusak Nugraha, Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Soedarsono Soedarsono, Department of Pulmonology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Pulmonology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

References

World Health Organization. Publication of tuberculosis. [Internet]. 2019. Cited from

https://www.who.int/news-room/fact-sheets/detail/tuberculosis. [accessed 30 June, 2019].

Pusat Data dan Informasi (Pusdatin) Kementerian Kesehatan Republik Indonesia. Tuberkulosis:

Temukan, obati sampai sembuh. Booklet Infodatin. [Internet]. 2018. Cited from http://www.pusdatin.

k e m k e s . g o . i d / a r t i c l e / v i e w / 1 6 0 8 0 3 0 0 0 0 2/-tuberkulosis-2016.html. [accessed 9 September, 2018].

Huang Z, Luo Q, Guo Y, Chen J, Xiong, et al. Mycobacterium tuberculosis-induced polarization of

human macrophage orchestrates the formation and development of tuberculous granulomas in-vitro.

PLos One, 2015; 10(6): e0129744.

Lugo-Villarino G, Verollet C, Maridonneau-Parini I, Neyrolles O. Macrophage polarization: Convergence point targetted by Mycobacterium tuberculosis and HIV. Frontiers in Immunology, 2011; 2: 43. Cited from www.ncbi.nlm.nih.gov/pmc/articles/PMC3342390/ [accessed 9 September, 2018].

Wang S, Zhang J, Sui L, Xu H, Piao Q, et al. Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis. Nature Scientific Reports, 2017; 7: 14982. Cited from https://www.nature.com/articles/s41598-017-14808-9. [accessed 12 August, 2018].

Fatima N, Shameem M, Nabeela, Khan PA, Khan HM. Correlation of serum IL-4 levels in new and MDR

tuberculosis patients. American Journal of Clinical and Experimental Medicine, 2015; 3(1): 48-51.

Labonte AC, Tosello TAC, Hahn YS. The role of macrophage polarization in infectious and inflammatory diseases. Molecules and Cells Journal, 2014; 37(4): 275-285.

Vidyarani M, Selvaraj P, Anand SP, Jawahar MS, Adhilaksmi AR, Narayanan PR. Interferon-gamma

(IFNγ) and interleukin-4 (IL-4) gene variants and cytokine levels in pulmonary tuberculosis. The Indian

Journal of Medical Research, 2006; 124(4): 403-10.

Ordway DJ, Costa L, Martins M, Silveira H, Amaral L, et al. Increased interleukin-4 production by CD8 and γδ1 T-cells in healthcare workers is associated with the subsequent development of active tuberculosis. The Journal of Infectious Disease, 2004; 190(4): 756-766.

Butov DO, Kuzhko MM, Makeeva NI, Butova TS, Stepanenko HL, Dudnyk AB. Association of interleukins genes polymorphisms with multidrug-resistant tuberculosis in Ukrainian population. Advances in Respiratory Medicine, 2016; 84(3): 168-173.

Downloads

Submitted

2020-01-06

Accepted

2020-04-21

Published

2020-12-07

How to Cite

[1]
Susanto, J., Nugraha, J. and Soedarsono, S. 2020. IL-4 Level in Rifampicin-Sensitive and Rifampicin-Resistant Lung Tuberculosis Patients. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 27, 1 (Dec. 2020), 46–50. DOI:https://doi.org/10.24293/ijcpml.v27i1.1606.

Issue

Section

Articles